Literature DB >> 20658621

Ventricular diastolic dysfunction in sickle cell anemia is common but not associated with myocardial iron deposition.

Jane S Hankins1, Mary Beth McCarville, Claudia M Hillenbrand, Ralf B Loeffler, Russell E Ware, Ruitian Song, Matthew P Smeltzer, Vijaya Joshi.   

Abstract

BACKGROUND: Cardiac failure from myocardial iron deposition is a severe complication in patients with transfusion-related iron overload. Progressive heart damage from iron overload can cause left ventricular systolic and diastolic dysfunction in patients with hematologic disorders. Since nontransfused patients with sickle cell anemia (SCA) have a high incidence of diastolic dysfunction, we investigated the relationships among transfusional iron burden, myocardial iron deposition, and diastolic ventricular dysfunction by T2*-MRI and tissue Doppler echocardiography in iron-overloaded children with SCA. PROCEDURE: Children (> or =7 years) with SCA and iron overload (serum ferritin >1,000 ng/ml or > or =18 lifetime transfusions) were eligible. Serum ferritin and hepatic iron content (HIC) were measured and participants underwent nonsedated T2*-MRI of the heart, echocardiogram, electrocardiogram, and multi-uptake gated acquisition (MUGA) scan. Age-matched normative echocardiographic data were used for comparison.
RESULTS: Among 30 children with SCA (median age, 13 years) and iron overload, mean (+/-SD) HIC and serum ferritin were 10.8 mg Fe/g (+/-5.9 mg Fe/g) and 3,089 ng/ml (+/-2,167 ng/ml), respectively. Mean T2*-MRI was 33 msec (+/-7 msec, range, 22-49). Echocardiography showed a high prevalence of diastolic dysfunction (77% and 45% abnormally low mean mitral annular velocity and mean tricuspid annular velocity, respectively); however, echocardiogram and MUGA scan findings were not significantly associated with HIC or T2*-MRI.
CONCLUSIONS: Diastolic dysfunction is not associated with transfusional iron burden or myocardial iron deposition among children with SCA. Diastolic dysfunction likely results from disease pathophysiology and severity rather than iron overload. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658621      PMCID: PMC3075427          DOI: 10.1002/pbc.22587

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  38 in total

1.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children.

Authors:  Benjamin W Eidem; Colin J McMahon; Radha R Cohen; Jin Wu; Irina Finkelshteyn; John P Kovalchin; Nancy A Ayres; Louis I Bezold; E O'Brian Smith; Ricardo H Pignatelli
Journal:  J Am Soc Echocardiogr       Date:  2004-03       Impact factor: 5.251

3.  Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients.

Authors:  G Barosi; E Arbustini; A Gavazzi; M Grasso; A Pucci
Journal:  Eur J Haematol       Date:  1989-04       Impact factor: 2.997

4.  Progression of iron overload in sickle cell disease.

Authors:  N F Olivieri
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

5.  Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major.

Authors:  R E Marcus; S C Davies; H M Bantock; S R Underwood; S Walton; E R Huehns
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

6.  Assessment of global left ventricular function in normal children and in children with dilated cardiomyopathy.

Authors:  G Eto; M Ishii; C Tei; T Tsutsumi; T Akagi; H Kato
Journal:  J Am Soc Echocardiogr       Date:  1999-12       Impact factor: 5.251

7.  Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Authors:  P Harmatz; E Butensky; K Quirolo; R Williams; L Ferrell; T Moyer; D Golden; L Neumayr; E Vichinsky
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

8.  Nitric oxide controls cardiac substrate utilization in the conscious dog.

Authors:  F A Recchia; P I McConnell; K E Loke; X Xu; M Ochoa; T H Hintze
Journal:  Cardiovasc Res       Date:  1999-11       Impact factor: 10.787

9.  Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload.

Authors:  M Vogel; L J Anderson; S Holden; J E Deanfield; D J Pennell; J M Walker
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

10.  Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle.

Authors:  J E Jalil; C W Doering; J S Janicki; R Pick; S G Shroff; K T Weber
Journal:  Circ Res       Date:  1989-06       Impact factor: 17.367

View more
  17 in total

Review 1.  Cardiovascular abnormalities in sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev
Journal:  J Am Coll Cardiol       Date:  2012-03-27       Impact factor: 24.094

2.  Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.

Authors:  Nihal Bakeer; Jeanne James; Swarnava Roy; Janaka Wansapura; Shiva Kumar Shanmukhappa; John N Lorenz; Hanna Osinska; Kurt Backer; Anne-Cecile Huby; Archana Shrestha; Omar Niss; Robert Fleck; Charles T Quinn; Michael D Taylor; Enkhsaikhan Purevjav; Bruce J Aronow; Jeffrey A Towbin; Punam Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

3.  Vascular complications of sickle cell disease.

Authors:  Ashar Usmani; Roberto F Machado
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

4.  Evaluation of myocardial deformation in patients with sickle cell disease and preserved ejection fraction using three-dimensional speckle tracking echocardiography.

Authors:  Homaa Ahmad; Etienne Gayat; Chattanong Yodwut; M Cristina Abduch; Amit R Patel; Lynn Weinert; Ankit Desai; Wendy Tsang; Joe G N Garcia; Roberto M Lang; Victor Mor-Avi
Journal:  Echocardiography       Date:  2012-05-08       Impact factor: 1.724

5.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

6.  Left ventricular rotational mechanics in Tanzanian children with sickle cell disease.

Authors:  Michael V Di Maria; Hao H Hsu; Ghassan Al-Naami; Jeanine Gruenwald; K Scott Kirby; Fenella J Kirkham; Sharon E Cox; Adel K Younoszai
Journal:  J Am Soc Echocardiogr       Date:  2014-12-30       Impact factor: 5.251

7.  [Echocardiographic aspects of sickle cell disease in Guadeloupe].

Authors:  Louis Igor Ondze-Kafata; Alain Sanouiller; Mona Hedreville; Segho Hedreville; Laurent Larifla
Journal:  Pan Afr Med J       Date:  2014-05-13

8.  Hormonal and echocardiographic abnormalities in adult patients with sickle-cell anemia in Bahrain.

Authors:  Taysir S Garadah; Ahmed A Jaradat; Mohammed E Alalawi; Adla B Hassan
Journal:  J Blood Med       Date:  2016-12-13

9.  Association of Anemia and Blood Pressure With Novel Markers of Diastolic Function in Pediatric Sickle Cell Disease.

Authors:  Simone Jhaveri; Nadine Choueiter; Deepa Manwani; Saritha Ranabothu; Kerry Morrone; Michael Hafeman; Kimberly Reidy; Frederick Kaskel; Joseph Mahgerefteh
Journal:  J Pediatr Hematol Oncol       Date:  2021-05-01       Impact factor: 1.289

Review 10.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.